Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioGross MarginInvested CapitalMarket Capitalization

Mainz Biomed N.V (MYNZ) FCF Margin: 2022-2023

Historic FCF Margin for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to -2,167.61%.

  • Mainz Biomed N.V's FCF Margin rose 27047.00% to -2,167.61% in Q4 2023 from the same period last year, while for Dec 2023 it was -2,449.96%, marking a year-over-year increase of 33741.00%. This contributed to the annual value of -1,923.39% for FY2024, which is 66044.00% up from last year.
  • Per Mainz Biomed N.V's latest filing, its FCF Margin stood at -2,167.61% for Q4 2023, which was up 39.47% from -3,580.98% recorded in Q3 2023.
  • In the past 5 years, Mainz Biomed N.V's FCF Margin ranged from a high of -2,056.17% in Q2 2023 and a low of -3,719.70% during Q3 2022.
  • For the 2-year period, Mainz Biomed N.V's FCF Margin averaged around -2,703.05%, with its median value being -2,547.25% (2022).
  • Data for Mainz Biomed N.V's FCF Margin shows a peak YoY skyrocketed of 60,025bps (in 2023) over the last 5 years.
  • Over the past 2 years, Mainz Biomed N.V's FCF Margin (Quarterly) stood at -2,438.08% in 2022, then surged by 27,047bps to -2,167.61% in 2023.
  • Its last three reported values are -2,167.61% in Q4 2023, -3,580.98% for Q3 2023, and -2,056.17% during Q2 2023.